Recursion Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary

Recursion Pharmaceuticals

07/11/2024 05:14

* Recursion Pharmaceuticals Inc  RXRX.OQ  reported a
quarterly
adjusted loss of 34 cents​​ per share for the quarter ended
September 30, higher than the same quarter last year, when the
company reported EPS of -43 cents.  The mean expectation of
eight analysts for the quarter was for a loss of 35 cents per
share. Wall Street expected results to range from -40 cents
to -28 cents per share.
    * Revenue rose 147.6% to $26.08 million from a year ago;
analysts
expected $29.84 million. 
    * Recursion Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 34 cents​.
    * The company reported a quarterly loss of $95.84 million.
    * Recursion Pharmaceuticals Inc shares had risen by 5.8%
this
quarter and lost 29.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 4.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 6
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Recursion
Pharmaceuticals Inc is 10.00 
This summary was machine generated from LSEG data November 7 at
05:14 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.35          -0.34          Beat
 Jun. 30 2024      -0.40          -0.40          Met
 Mar. 31 2024      -0.42          -0.39          Beat
 Dec. 31 2023      -0.45          -0.42          Beat